NEW YORK (GenomeWeb News) – Bio-Reference Laboratories today said that it will consider expanding into pharmacogenomics testing now that it will acquire specialty testing shop GeneDx.
 
Entering the molecular diagnostics market, including the drug-monitoring space, is one option that is “on the table,” Amar Kamath, marketing director for Bio-Reference’s molecular business, told GenomeWeb News today.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.